Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7NAL

Cryo-EM structure of activated human SARM1 in complex with NMN and 1AD (ARM and SAM domains)

Summary for 7NAL
Entry DOI10.2210/pdb7nal/pdb
EMDB information24273
DescriptorNAD(+) hydrolase SARM1, BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE (2 entities in total)
Functional Keywordsnadase, axon degeneration, inhibitor, complex, hydrolase
Biological sourceHomo sapiens (Human)
Total number of polymer chains8
Total formula weight614453.57
Authors
Kerry, P.S.,Nanson, J.D.,Adams, S.,Cunnea, K.,Bosanac, T.,Kobe, B.,Hughes, R.O.,Ve, T. (deposition date: 2021-06-21, release date: 2022-03-23, Last modification date: 2025-05-28)
Primary citationShi, Y.,Kerry, P.S.,Nanson, J.D.,Bosanac, T.,Sasaki, Y.,Krauss, R.,Saikot, F.K.,Adams, S.E.,Mosaiab, T.,Masic, V.,Mao, X.,Rose, F.,Vasquez, E.,Furrer, M.,Cunnea, K.,Brearley, A.,Gu, W.,Luo, Z.,Brillault, L.,Landsberg, M.J.,DiAntonio, A.,Kobe, B.,Milbrandt, J.,Hughes, R.O.,Ve, T.
Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules.
Mol.Cell, 82:1643-, 2022
Cited by
PubMed Abstract: The NADase SARM1 (sterile alpha and TIR motif containing 1) is a key executioner of axon degeneration and a therapeutic target for several neurodegenerative conditions. We show that a potent SARM1 inhibitor undergoes base exchange with the nicotinamide moiety of nicotinamide adenine dinucleotide (NAD) to produce the bona fide inhibitor 1AD. We report structures of SARM1 in complex with 1AD, NAD mimetics and the allosteric activator nicotinamide mononucleotide (NMN). NMN binding triggers reorientation of the armadillo repeat (ARM) domains, which disrupts ARM:TIR interactions and leads to formation of a two-stranded TIR domain assembly. The active site spans two molecules in these assemblies, explaining the requirement of TIR domain self-association for NADase activity and axon degeneration. Our results reveal the mechanisms of SARM1 activation and substrate binding, providing rational avenues for the design of new therapeutics targeting SARM1.
PubMed: 35334231
DOI: 10.1016/j.molcel.2022.03.007
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3 Å)
Structure validation

237992

数据于2025-06-25公开中

PDB statisticsPDBj update infoContact PDBjnumon